ADVERTISEMENT

Spirituality, patients' worry, and follow-up health-care utilization among cancer survivors

Author and Disclosure Information

 

 

Table 1. Demographic Characteristics of Cancer Survivors in This Study

EVALUABLE (N)
LOW SPIRITUALITY
HIGH SPIRITUALITY
P
  FREQUENCYPERCENTFREQUENCYPERCENT 
n5512714928051 
Median age (range)59 (19–85)59 (22–83)0.99
 ≤405511762180.78
 41–60 1375113548 
 >60 1174312444 
Sex
 Female5511124189320.02
 Male 1595919168 
Race/ethnicity
 White55125694272970.21
 Hispanic 6221 
 African American 3141 
 Other 6221 
Marital status
 Single/never married5511451970.67
 Married 2198121978 
 Divorced/widowed 38144215 
Education
 High school551903383300.49
 College 1053912244 
 Postgraduate 76287527 
Religion
 Protestant5511214516158<0.01
 Catholic 101378029 
 Other 36133513 
 None/atheist 13541 
Income (US$)
 <25,000551371437130.71
 25,000–49,999 64246122 
 50,000–74,999 59225419 
 75,000–100,000 35134416 
 >100,000 57215620 
 Missing 1972810 
Place of residence
 Urban55119472201720.96
 Rural 77287928 
Distance (miles)
 ≤155511084098350.32
 15–100 83319434 
 100–250 44165821 
 >250 36133011 
Employment status
 Full time55116059163580.93
 Part time 2282710 
 Homemaker 259269 
 Student 3141 
 Retired 48185118 
 Other 13593 
Patient is the primary income provider55113751132470.42
Insurance
 Employer-based55114955153550.95
 Individual-based 47174817 
 Medicare/Medicaid 56215921 
 Other 176166 
 None 2141 
 Prescription insurance55123988242860.53
Type of malignancy
 Leukemia, lymphoma, multiple myeloma55113650147530.86
 Breast, colon, prostate 1013710036 
 Lung, pancreatic 34133312 
Median time from diagnosis to study enrollment in years (range)4.5 (0.5–26.6)4.2 (0.6–26.6)0.28
 0–2 years551562162220.09
 2–4 years 70267627 
 4–8 years 74279333 
 >8 years 71264918 
Median time from last treatment to study enrollment in years (range)3.6 (0.1–13.6)3.6 (0.4–18.7)0.87
 0–2 years551973699350.84
 2–5 years 83319233 
 >5 years 91348932 
Affiliation of follow-up provider
 University-based55119371190680.16
 Community-based 28103111 
 Both 50185419 
 Missing 0052 
Treatment received
 Chemotherapy only551823089320.93
 Chemo + surgery + radiation 1254612645 
 Stem cell transplantation 64246523 
Prior treatment outside university55111643126450.60

Statistical Analysis

Participant characteristics were compared according to level of spirituality using a chi-square test for categorical data and the Wilcoxon test for continuous data (Table 1). Multivariate logistic regression models were fitted to evaluate separately the relationship between (1) spirituality with patient-rated worry as the outcome, (2) spirituality with follow-up health-care utilization as the outcome, and (3) patient-rated worry with follow-up health-care utilization as the outcome. In the above models, the following covariates were forced into each model: age, sex, cancer type, time from last cancer-related treatment to study start time, income, and type of medical insurance. These models were also fitted using outcomes ascertained at both 6 and 12 months. Interaction models between patient-rated worry and level of spirituality were also evaluated for an association with follow-up health-care utilization at 12 months to explore the role of spirituality in the relationship between patient-rated worry and health-care utilization. A P value of at least 0.05 was considered statistically significant.

Results

Study Participation

Of the 2,000 participants invited, 1,881 were deemed eligible (minus those who died or had wrong addresses). Baseline questionnaires were returned by 939 participants (baseline response rate of 50%). Seventeen wanted to participate only in the baseline survey. Of the 922 baseline participants, 691 returned the 6-month survey at the time of the analysis for this study, for a response rate of 76% when adjusted for deaths (182 no response, 18 deaths, 25 declined, 12 returned with wrong address). At 1 year, 691 surveys were mailed, with 588 surveys returned (58 no response, 17 deaths, 14 declined, 13 returned with wrong address, and one in hospice); a response rate of 87% was achieved after adjusting for deaths. Thirty-seven participants had missing information on spirituality, leaving a total of 551 included in this study. No differences in age, sex, and type of cancer were noted between patients included and excluded in the current analysis.

Characteristics of Study Participants

Demographic characteristics of the 551 study participants included in this study are shown in Table 1. We found that cancer survivors with low or high spirituality were more similar than different in all but two characteristics: highly spiritual survivors were more likely to be Protestant and male.

Prevalence of Spirituality and Patient Worry

Within our population, 271 (49%) survivors reported low spirituality and 280 (51%) reported high spirituality (Table 1). Also, at baseline, 277 (51%) survivors reported high levels of recurrence/progression-related worry, 190 survivors (35%) reported high levels of new malignancy–related worry, and 178 survivors (33%) reported high levels of treatment-related complication worry. As some participants may have reported one or more types of worry, this translates to 322 (59%) reporting any type of worry. Highly spiritual survivors reported significantly lower levels of high worry concerning recurrence/progression (6-month 27% vs. 38%, P < 0.01; 12-month 21% vs. 38%, P < 0.01), development of a different type of cancer (6-month 22% vs. 31%, P = 0.03; 12-month 15% vs. 26%, P < 0.01), and complications from treatment (6-month 17% vs. 30%, P < 0.01; 12-month 16% vs. 26%, P < 0.01). Highly spiritual survivors reported significantly lower levels for any type of worry at both 6 and 12 months (6 months 37% vs. 54%, P <0.01; 12 months 28% vs. 47%, P < 0.01) (Table 2).

Table 2. Common Worries of Cancer Survivors According to Level of Spirituality


BASELINE
6-MONTH
12-MONTH
  LOW SPIRITUALITY, N (%)HIGH SPIRITUALITY, N (%)PLOW SPIRITUALITY, N (%)HIGH SPIRITUALITY, N (%)PLOW SPIRITUALITY, N (%)HIGH SPIRITUALITY, N (%)P
Recurrence/progression-related worryLow106 (40)160 (58)<0.01154 (62)184 (73)<0.01166 (62)218 (79)<0.01
 High160 (60)117 (42) 95 (38)69 (27) 103 (38)59 (21) 
New primary–related worryLow158 (59)200 (72)<0.01172 (69)202 (78)0.03199 (74)235 (85)<0.01
 High111 (41)79 (28) 76 (31)58 (22) 71 (26)42 (15) 
Complication-related worryLow166 (61)203 (73)<0.01175 (70)214 (83)<0.01200 (74)232 (84)<0.01
 High104 (39)74 (27) 74 (30)45 (17) 69 (26)44 (16) 
Any worryLow85 (32)138 (50)<0.01120 (46)165 (63)<0.01142 (53)198 (72)<0.01
 High182 (68)140 (50) 139 (54)97 (37) 128 (47)78 (28)